A sweeping analysis of nearly 10,000 patients challenges assumptions about how best to treat knee osteoarthritis.

Mark Stein, MD, explores managing mHSPC through PSMA PET imaging, tumor burden assessment, and AMPLITUDE trial data while considering clinical context. The widespread adoption of PSMA PET imaging has ...

Around it, they trace patterns: health data, neighborhood boundaries, and emerging questions of community need. The students ...

As artificial intelligence technologies advance, many health systems are shifting attention from specialized AI tools for ...

The panel voted six to three that the available evidence doesn't support switching patients to AstraZeneca's camizestrant based on ESR1 mutations detected in circulating tumor DNA.

Red light therapy masks and devices are hugely popular in the beauty world, as they combat the signs of anti-ageing and make ...

Stem-cell memory T (TSCM) cells are a rare subset of immune cells with the ability to self-renew, persist long term, and ...

When a heart races at 200 beats per minute and refuses to slow down, the usual rescue involves threading a catheter through a ...

Chimeric antigen receptor-T (CAR-T) cell therapy represents a major breakthrough in cancer immunotherapy, providing remarkable clinical benefits for ...

The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...

Although patients with the same cancer diagnosis may respond very differently to treatment, clinicians still have limited ...

Across the nation, A.I. programs are quietly recording these conversations and turning them into draft medical notes. These ...